Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc. V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is committed to becoming a health innovator and applying technologies at the forefront of science to core health issues at the community pharmacy level. The Company’s goal is to empower consumers, patients and pharmacists with innovative technology, products, services and information to monitor and optimize health.


TSXV:AVCR - Post by User

Bullboard Posts
Post by kingposton Jan 09, 2016 4:00pm
189 Views
Post# 24443557

Generics Trivia -- Bangladesh, across the Bengal Bay

Generics Trivia -- Bangladesh, across the Bengal BayBangladesh is the only LDC (least developeed country) with a pharmaceutical industry -- actually growing fast now. With its LDC status it is the only country in the world  (due both to WTO status and ability) that can legally copy  branded drugs (while still under patent)  and market internally and to the other 49 LDC countries... IMO this will give this country a huge boost for the generics sector in the future -- since they will already have their plants up and running before others when patents come off...  Maybe next trip to India Arun should plan a trip across the Bengal Bay...


"After the inclusion of the Doha declaration in WTO / TRIPS Agreement, each and every country belonging to the least developed country (LDC) category has the option not to opt for pharmaceutical product patent until 2016. This means they can now legally reverse engineer patented products and sell in their markets as well as can export to other LDCs. This creates a huge export opportunities for Bangladesh, because, among all the 50 LDCs, Bangladesh has a strong base for the pharma manufacturing. Besides direct export operations, there is also a huge opportunity for the Bangladeshi companies to go for the contract manufacturing and compulsory licensing"
Bullboard Posts